Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter Buys Gambro For $4 Billion To Round Out Dialysis Device Lineup

This article was originally published in The Gray Sheet

Executive Summary

Deal builds on Baxter’s home peritoneal dialysis-focused business by adding a suite of products for hemodialysis in the clinic, including Gambro’s Artis and AK 96 systems.

You may also be interested in...



Nightly Home Hemodialysis Gains First FDA Clearance

NxStage’s System One has received an expanded indication to treat patients overnight at home, which the company says improves quality of life.

Baxter Spins Off Drug Business To Focus On Devices, Anesthesia & Nutrition Products

Kidney dialysis and biosurgery will be two major focus points for a newly refined Baxter after it spins off its biopharmaceuticals business, as planned for mid-2015.

$14 Billion Of Device M&A Activity In Q3, More On The Way

Propelled by the completion of two large acquisitions, the previous quarter was a strong one for device industry M&A activity, and indicators suggest the deal making will continue, PricewaterhouseCoopers says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT031798

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel